Patients Win in Supreme Court Gene Patent Decision

Northfield, IL – June 13, 2013, -- The College of American Pathologists applauds today’s unanimous Supreme Court decision invalidating the patents held by Myriad Genetics on the BRCA1 and BRCA2 genes. It is a victory for patients and for science. CAP is a co-plaintiff in the case Association of Molecular Pathology et al, vs Myriad Genetics, Inc., which the court decided today. “This is a landmark decision,” said CAP President, Stanley Robboy MD, FCAP. “Genomic medicine has the potential to be a cornerstone of medical testing, treatment, and clinical integration, but the question of “